Astroblastoma is a rare glial tumor with uncertain histopathological origin and unpredictable clinical behavior. We present a case of an 11-year-old girl who presented with headache and blurring of vision for 2 months. A well-demarcated mass was found in the right frontoparietal lobe on a brain MRI. The patient was treated with total tumor resection followed by postoperative radiotherapy. Histologically, the features were suggestive of high-grade astroblastoma. The patient is alive and disease free 23 months after surgery. The characteristic radiological and histopathological features and treatment of this case are described with a literature review.

Keywords:
Astroblastoma, Prognosis, Treatment, Pediatric patients
1.
Bonnin JM, Rubinstein LJ: Astroblastomas: a pathological study of 23 tumors, with a postoperative follow-up in 13 patients. Neurosurgery 1989;25:6–13.
2.
Bailey P, Cushing H: A classification of the tumors of the glioma group on a histogenetic basis with a correlated study of prognosis. Philadelphia, Lippincott 1926, pp 83–84, 134–167.
3.
Husain AN, Leestma JE: Cerebral astroblastoma: immunohistochemical and ultrastructural features. Case report. J Neurosurg 1986;64:657–661.
4.
Jay V, Edwards V, Squire J, Rutka J: Astroblastoma: report of a case with ultrastructural, cell kinetic, and cytogenetic analysis. Pediatr Pathol 1993;13:323–332.
5.
Bell JW, Osborn AG, Salzman KL, et al: Neuroradiologic characteristics of astroblastoma. Neuroradiology 2007;49:203–209.
6.
Fuller GN, Scheithauer BW: The 2007 revised World Health Organization (WHO) classification of tumours of the central nervous system: newly codified entities. Brain Pathol 2007;17:304–307.
7.
Sughrue ME, Choi J, Rutkowski MJ, et al: Clinical features and post-surgical outcome of patients with astroblastoma. J Clin Neurosci 2011;18:750–754.
8.
Navarro R, Reitman AJ, de León GA, et al: Astroblastoma in childhood: pathological and clinical analysis. Childs Nerv Syst 2005;21:211–220.
9.
Thiessen B, Finlay J, Kulkarni R, Rosenblum MK: Astroblastoma: does histology predict biologic behavior? J Neurooncol 1998;40:59–65.
10.
Brat DJ, Hirose Y, Cohen KJ, et al: Astroblastoma: clinicopathologic features and chromosomal abnormalities defined by comparative genomic hybridization. Brain Pathol 2000;10:342–352.
11.
Port JD, Brat DJ, Burger PC, Pomper MG: Astroblastoma: radiologic-pathologic correlation and distinction from ependymoma. AJNR Am J Neuroradiol 2002;23:243–247.
12.
Mangano FT, Bradford AC, Mittler MA, et al: Astroblastoma. Case report, review of the literature, and analysis of treatment strategies. J Neurosurg Sci 2007;51:21–27.
13.
Unal E, Koksal Y, Vajtai I, et al: Astroblastoma in a child. Childs Nerv Syst 2008;24:165–168.
14.
Kemerdere R, Dashti R, Ulu MO, et al: Supratentorial high grade astroblastoma: report of two cases and review of the literature. Turk Neurosurg 2009;19:149–152.
15.
Kantar M, Ertan Y, Turhan T, et al: Anaplastic astroblastoma of childhood: aggressive behavior. Childs Nerv Syst 2009;25:1125–1129.
16.
Mastrangelo S, Lauriola L, Coccia P, et al: Two cases of pediatric high-grade astroblastoma with different clinical behavior. Tumori 2010;96:160–163.
17.
Johnson KA, Bonnin JM, Boaz JC, et al: Anaplastic astroblastoma presenting as massive, sudden-onset, intraparenchymal hemorrhage. Pediatr Neurosurg 2010;46:457–461.
18.
Caroli E, Salvati M, Esposito V, et al: Cerebral astroblastoma. Acta Neurochir (Wien) 2004;146:629–633.
© 2012 S. Karger AG, Basel
2012
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.